Skip to content
  • About us
    • Overview
    • Our founders
    • Careers
  • Our pipeline
    • Development pipeline
    • Netazepide
      • Background
      • Studies
      • Further studies
    • Ceclazepide
    • TR4
    • TR8
  • Trio Medicines Logo
  • Our publications
  • Contact us
Previous Next

Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.

Boyce M, Dowen S, Turnbull G, van den Berg F, Zhao C-M, Chen D, Black JW. Effect of netazepide, a gastrin receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia: randomised controlled trial in healthy subjects.  Br J Clin Pharmacol 2015; 79: 744–755.

myarzi12019-03-26T13:17:41+00:00Netazepide|

Share This Story, Choose Your Platform!

FacebookTwitterLinkedInRedditGoogle+TumblrPinterestVkEmail